COVID-19 Monoclonal Antibody Treatment
If you are currently COVID-positive patient, ask your doctor if monoclonal antibody treatment is right for you.
What are monoclonal antibodies?
Monoclonal antibodies are produced in a laboratory. They serve as substitute antibodies that help our immune systems mimic the defense of natural COVID-19 antibodies. Currently, Lee Health is using the monoclonal antibody Casirivimab/Imdevimab (Regeneron) to treat certain COVID-19 patients.
How can I receive monoclonal antibody treatment?
Currently, Lee Health is utilizing monoclonal antibody treatment for COVID-19 patients who have mild-to-moderate symptoms and are at high risk of developing severe symptoms or the need for hospitalization.
A physician referral is required for monoclonal antibody treatment, and the patient must have a positive COVID-19 test, be in their first seven (7) days of showing symptoms and meet certain risk factors as required by the FDA.
If you are a COVID-positive patient and are interested in receiving monoclonal antibody treatment, speak with your doctor to see if it is right for you.
How is monoclonal antibody treatment administered?
Monoclonal antibodies are administered via an IV infusion in an outpatient setting. The treatment typically lasts about two and a half hours. Lee Health is performing these infusions 7-days per week at the following locations:
Complex Care Center at Lee Memorial Hospital
2776 Cleveland Ave, Ft. Myers, FL 33901
Complex Care Center at Coconut Point
23450 Via Coconut Point, Estero, FL 33928
Complex Care Center at Cape Coral Hospital
708 Del Prado Blvd S, Cape Coral, FL 33990